TRCT
CC icon

Tower Research Capital (TRC)’s Chemours CC Stock Holding History

Tower Research Capital (TRC)’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$298K Buy
13,523
+1,477
+12% +$25.7K 0.01% 1306
2025
Q4 		$142K Buy
12,046
+137
+1% +$1.76K ﹤0.01% 1710
2025
Q3 		$189K Sell
11,909
-214
-2% -$3.1K 0.01% 1508
2025
Q2 		$139K Buy
12,123
+1,925
+19% +$21.7K ﹤0.01% 2107
2025
Q1 		$138K Sell
10,198
-13,939
-58% -$231K ﹤0.01% 1592
2024
Q4 		$408K Buy
24,137
+13,082
+118% +$255K 0.01% 1211
2024
Q3 		$225K Sell
11,055
-14,269
-56% -$292K 0.01% 1523
2024
Q2 		$572K Buy
25,324
+15,595
+160% +$408K 0.01% 1229
2024
Q1 		$255K Sell
9,729
-9,414
-49% -$268K 0.01% 1258
2023
Q4 		$604K Buy
19,143
+9,520
+99% +$258K 0.01% 1224
2023
Q3 		$270K Buy
9,623
+2,443
+34% +$83.9K 0.01% 1248
2023
Q2 		$265K Sell
7,180
-5,667
-44% -$173K 0.01% 1370
2023
Q1 		$384K Buy
12,847
+6,369
+98% +$210K 0.01% 990
2022
Q4 		$198K Sell
6,478
-24,605
-79% -$738K 0.01% 1308
2022
Q3 		$766K Buy
31,083
+21,386
+221% +$705K 0.01% 833
2022
Q2 		$310K Sell
9,697
-2,522
-21% -$92.8K 0.01% 1455
2022
Q1 		$385K Sell
12,219
-2,856
-19% -$89.3K ﹤0.01% 1312
2021
Q4 		$506K Buy
15,075
+10,292
+215% +$321K 0.01% 1101
2021
Q3 		$139K Sell
4,783
-18,030
-79% -$584K ﹤0.01% 2127
2021
Q2 		$794K Buy
22,813
+16,181
+244% +$536K 0.02% 821
2021
Q1 		$185K Sell
6,632
-31,344
-83% -$834K ﹤0.01% 2073
2020
Q4 		$941K Buy
37,976
+5,472
+17% +$130K 0.03% 556
2020
Q3 		$679K Buy
32,504
+5,076
+19% +$98K 0.01% 1350
2020
Q2 		$421K Buy
27,428
+15,706
+134% +$199K 0.02% 1169
2020
Q1 		$104K Buy
11,722
+10,567
+915% +$152K 0.01% 976
2019
Q4 		$21K Sell
1,155
-123
-10% -$2.04K ﹤0.01% 1881
2019
Q3 		$19K Sell
1,278
-13,559
-91% -$221K ﹤0.01% 2495
2019
Q2 		$356K Buy
14,837
+9,604
+184% +$283K 0.02% 620
2019
Q1 		$194K Buy
5,233
+3,894
+291% +$142K 0.01% 1134
2018
Q4 		$38K Sell
1,339
-22,376
-94% -$708K ﹤0.01% 1463
2018
Q3 		$936K Buy
23,715
+16,907
+248% +$740K 0.07% 223
2018
Q2 		$302K Sell
6,808
-11,068
-62% -$551K 0.02% 862
2018
Q1 		$871K Buy
17,876
+17,223
+2,638% +$861K 0.07% 235
2017
Q4 		$33K Sell
653
-347
-35% -$18.2K ﹤0.01% 1658
2017
Q3 		$51K Buy
+1,000
New +$47.2K ﹤0.01% 1949
2017
Q2 		– Sell
-634
Closed -$24K – 2751
2017
Q1 		$24K Sell
634
-2,038
-76% -$61.3K ﹤0.01% 1164
2016
Q4 		$59K Buy
+2,672
New +$54.9K 0.01% 1313
2016
Q3 		– Sell
-5,886
Closed -$48K – 3687
2016
Q2 		$48K Buy
5,886
+4,222
+254% +$37.6K ﹤0.01% 1577
2016
Q1 		$11K Sell
1,664
-7,917
-83% -$39.8K ﹤0.01% 1846
2015
Q4 		$51K Buy
+9,581
New +$61.2K 0.01% 547

Other funds holding CC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
WHCM
Wolf Hill Capital Management Greenwich, Connecticut $1.03B AUM 80.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Tower Research Capital (TRC)'s CC Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Chemours (CC) stake by 12% in Q1 2026, buying an estimated $25.7K and bringing the position to 13,523 shares worth $298K. The position accounts for 0.01% of the portfolio, ranked #1306.

Tower Research Capital (TRC) first reported a position in CC in Q4 2015 and has held it in 40 quarters since. The position peaked at $941K in Q4 2020. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Tower Research Capital (TRC) held 13,523 shares of Chemours worth $298K as of Q1 2026.
  • Tower Research Capital (TRC) bought 1,477 Chemours shares in Q1 2026, an estimated $25.7K.
  • Chemours made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1306 holding.
  • Tower Research Capital (TRC) first reported a position in Chemours in Q4 2015 and has held it in 40 quarters since.
  • Tower Research Capital (TRC)'s Chemours position peaked at $941K in Q4 2020.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.